[{"address1": "455 East Medical Center Boulevard", "address2": "Suite 300", "city": "Houston", "state": "TX", "zip": "77598", "country": "United States", "phone": "281-651-5150", "website": "https://www.fibrobiologics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter  O'Heeron", "age": 60, "title": "Founder, Chairperson & CEO", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 1016747, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.86, "open": 0.86, "dayLow": 0.8, "dayHigh": 0.8752, "regularMarketPreviousClose": 0.86, "regularMarketOpen": 0.86, "regularMarketDayLow": 0.8, "regularMarketDayHigh": 0.8752, "payoutRatio": 0.0, "forwardPE": -2.25, "volume": 202679, "regularMarketVolume": 202679, "averageVolume": 195979, "averageVolume10days": 197000, "averageDailyVolume10Day": 197000, "bid": 0.595, "ask": 1.05, "bidSize": 2, "askSize": 2, "marketCap": 30992706, "fiftyTwoWeekLow": 0.763, "fiftyTwoWeekHigh": 13.59, "fiftyDayAverage": 0.9875, "twoHundredDayAverage": 1.91535, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 29441694, "profitMargins": 0.0, "floatShares": 28459329, "sharesOutstanding": 38262600, "sharesShort": 1589746, "sharesShortPriorMonth": 2251750, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.041500002, "heldPercentInsiders": 0.21368, "heldPercentInstitutions": 0.16863, "shortRatio": 6.34, "shortPercentOfFloat": 0.0493, "impliedSharesOutstanding": 38262600, "bookValue": 0.062, "priceToBook": 13.064516, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -7667000, "trailingEps": -0.21, "forwardEps": -0.36, "enterpriseToEbitda": -2.011, "52WeekChange": -0.9324437, "SandP52WeekChange": 0.09362543, "quoteType": "EQUITY", "currentPrice": 0.81, "targetHighPrice": 16.0, "targetLowPrice": 4.0, "targetMeanPrice": 10.75, "targetMedianPrice": 11.5, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 8667000, "totalCashPerShare": 0.227, "ebitda": -14643000, "totalDebt": 7116000, "quickRatio": 1.056, "currentRatio": 1.136, "debtToEquity": 302.809, "returnOnAssets": -0.8115, "freeCashflow": -17738250, "operatingCashflow": -12901000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "FBLG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketChangePercent": 6.17284, "postMarketPrice": 0.86, "postMarketChange": 0.05, "regularMarketChange": -0.050000012, "regularMarketDayRange": "0.8 - 0.8752", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 195979, "fiftyTwoWeekLowChange": 0.04699999, "fiftyTwoWeekLowChangePercent": 0.061598938, "fiftyTwoWeekRange": "0.763 - 13.59", "fiftyTwoWeekHighChange": -12.78, "fiftyTwoWeekHighChangePercent": -0.9403973, "fiftyTwoWeekChangePercent": -93.24437, "epsTrailingTwelveMonths": -0.21, "epsForward": -0.36, "epsCurrentYear": -0.475, "priceEpsCurrentYear": -1.7052631, "fiftyDayAverageChange": -0.17750001, "fiftyDayAverageChangePercent": -0.17974684, "twoHundredDayAverageChange": -1.10535, "twoHundredDayAverageChangePercent": -0.5771008, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-01-31", "averageAnalystRating": "1.7 - Buy", "corporateActions": [], "postMarketTime": 1748041574, "regularMarketTime": 1748030401, "exchange": "NCM", "messageBoardId": "finmb_1758633149", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "FibroBiologics, Inc.", "longName": "FibroBiologics, Inc.", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1706797800000, "regularMarketChangePercent": -5.813955, "regularMarketPrice": 0.81, "marketState": "CLOSED", "displayName": "FibroBiologics", "trailingPegRatio": null, "__fetch_time": "2025-05-24"}]